Sep 15, 2023 | Business
Mitsubishi Heavy Industries, Ltd. (MHI) is advancing the development of mankind’s lunar exploration by participating in a series of domestic and international space programs. Through the contributions of these programs, which are based on our unparalleled heritage in space technologies, built over many years of space development, MHI will help launch a new era in lunar exploration and expanding the life in space half a century after the Apollo programs.
1. Environmental control and life support system (ECLSS) development for the international habitation module (I-HAB) to be used on the Gateway crewed space station
As part of the Artemis program, an international space exploration program led by NASA, MHI is working under JAXA to develop environmental control and life support system (ECLSS) for the international habitation module (I-HAB) for Gateway, the crewed space station that will serve as a base for lunar exploration. MHI is committed to successfully developing ECLSS, the core life support capabilities for I-HAB.
The Artemis program, which unites the space agencies from the USA, Europe, Canada, Japan and other countries who developed the International Space Station (ISS), has as its principal objective of “establishing a base for human activity on the moon.” Gateway is considered the centerpiece of the program and will be built in lunar orbit to serve as a habitable transit base for astronauts heading to the moon for lunar exploration.
MHI will develop ECLSS, based on its experience of development and years of operating the Japanese Experiment Module (JEM) for the ISS and HTV. ECLSS enables the creation of an environment that allows humans to live in space by supplying fresh air while removing CO2 and harmful contaminants from a confined space. ECLSS is a technology that will be indispensable also for the exploration of Moon, Mars and beyond.
2. Exploration rover development for LUPEX, the Lunar Pole area Exploration program, and Toyota’s manned pressurized rover assessment support
MHI is working on the development of an exploration rover for the Lunar Pole Exploration program (LUPEX), a collaborative program between JAXA and the Indian Space Research Organization (ISRO). The project aims to collect data regarding the quantity and quality of water resources on the moon, to determine whether such water can be used for future sustained space exploration. MHI will utilize the results from in-house research to develop off-road vehicle traveling technology that will be used to survey polar areas of the moon where water may be present.
Once completed, the rover will be loaded onto a lunar lander developed by ISRO and launched by Japan’s H3 launch vehicle in the mid-2020s.
The traveling technology and lunar data collected by the rover are expected to be used to support the manned pressurized rover development. Building on technological heritage in spacecraft integration, space environmental resistance and human space stay, MHI is supporting Toyota Motor Corporation and JAXA assessment on manned pressurized rover enabling astronauts to drive on the moon with no need to wear heavy space suits.
3. Supporting an assessment of the cargo transfer vehicle for Gateway, building on the successful flight track record of HTV
MHI has been involved in the development of all nine successful flights of the HTV (H-II Transfer Vehicle) and its successor HTV-X. Building on these heritages, MHI is supporting JAXA’s assessment of the cargo transfer vehicle to Gateway space station.
For more information, visit www.mhi.com/news/23091401.html.
About MHI Group
Mitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com.
Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Jan 9, 2022 | Business
SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.
The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an end. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case scenario could effectively kill parallel distribution.
This conference will bring together industry experts to discuss the challenges and drivers of the industry, including the EU regulatory landscape and the impact of the Brexit and the Pandemic together. The conference will also provide global insights on Parallel trade and will reflect on key takeaways for other member states.
Book on or before 28th January to receive £100 off the conference price
Register online today at: www.parallel-trade.com or call Yasmin Alsadoon, Director on +44 (0)20 7827 6164 or email yalsadoon@smi-online.co.uk.
Co-Chairs For 2022:
· Christopher Stothers, Partner, Freshfields Bruckhaus Deringer LLP
· Eric Noehrenberg, Vice President and Global Head of Market Access and Goverment Affairs, Corcym
Key Speakers Include:
· Martin Howe, Queen’s Counsel, 8 New Square
· Shabnam Hanassab, Engagement Manager, iQvia
· Tushar Patel, Technical Director, Key Pharmaceuticals Ltd
· Dermot Glynn, Senior Advisor, Europe Economics
· Stefan Enchelmaier, Professor of European and Comparative Law, Tutor in Jurisprudence, lincoln College, GB-Oxford
· Hynek Valerián, Group Parallel Trade Manager, Dr. Max group
· Jackie Mulryne, Partner, Arnold & Porter
· Peter Bogaert, Managing Partner, Covington & Burling
· and many more
Key Benefits of attending:
– Discover the impact of Covid-19 on Parallel trade as countries begin to release restrictions. How has the sector been influenced?
– Engage in discussions on the growth within parallel trade over the past year at the only Parallel Trade specific conference within the EU.
– Discuss the impact on UK parallel trade following Brexit, through the eyes of regulators, the pharmaceutical industry and academics
– Develop further understanding of the rules and regulation changes over the past 12 months, Parallel Trade, where are we now?
Who should attend:
Vice President/ Heads of/General Managers:
· International Trade and Relations
· Supply Chain Development – Brexit
· Brexit Implementation
· Market Access
· Supply Chain Manager
· Parallel trade reporting
· Regulatory Affairs
· IP
· Purchasing
· Policy Patent Operations
· European Affairs
· Supply and Demand
· Attorney
· Distribution
SMi Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages.
Plus, Two post-conference interactive workshops
Workshop A : Parallel Trade let’s talk details
Workshop Leader: Tushar Patel, Technical Director, Key Pharmaceuticals Ltd.
Workshop Overview: This workshop will discuss all of the main topics within parallel trade, looking back to understand the future. There will be highlights on the history of parallel imports and how this works with the UK. The workshop will also highlight parallel trade and Brexit, discussing where we are now and what strategies are currently being used, do they give parallel traders and advantage and how will Brexit effect parallel trade in the long term. The workshop will highlight the challenges and successes of the industry and will also allow for open discussion on the future of this industry.
This workshop will allow you to:
• Discover the future of parallel trade, based on the history we have
• Understand where we are now, how has Brexit effected the parallel
trade industry
• Interact with industry professionals with Q&A sessions.
• Speak with Tushar Patel about current trading models and the specific
challenges for different industry professionals.
Workshop B: The Case Law of Parallel Imports
Workshop Leader: Stefan Enchelmaier, Professor of European and Comparative Law, Tutor in Jurisprudence, Lincoln College, GB-Oxford
Workshop Overview: This workshop will allow attendees to discuss and build their understanding of case law within Parallel Trade. With interactive sessions, opportunities to question and learn, this workshop will discuss national IP rights and the trade of COVID-19 vaccines. There will be highlights of Professor Stefan Enchelmaier’s work and case studies, focusing on re-packaging and intellectual property.
This workshop will allow you to:
• Discover when parallel trade is permissible
• Engage in interactive sessions about case law with a focus on packaging
• Discuss potential cases with Stefan and understand develop your understanding of the movement of free goods.
Additional Contact Info:
T: +44 (0)20 7827 6088
E: rjones@smi-online.co.uk
W: www.parallel-trade.com/
LinkedIn: @SMi Pharma
Twitter: @SMiPharm #SMi #SMiParallel
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk.